发明名称 |
TREATMENT OF JAK2-MEDIATED CONDITIONS |
摘要 |
Described herein is a method for treating a subject experiencing anemia, comprising administering to the subject an amount of N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-benzamide [CYT387 ] or a related compound effective to maintain or elevate the hemoglobin level. The anemic subjects including those afflicted with a myeloproliferative disorder, such as primary myelofibrosis. |
申请公布号 |
US2014073643(A1) |
申请公布日期 |
2014.03.13 |
申请号 |
US201113991139 |
申请日期 |
2011.11.29 |
申请人 |
SMITH GREGG D.;FIDA ROSE;KOWALSKI MARK M.;YM BIOSCIENCES AUSTRALIA PTY LTD |
发明人 |
SMITH GREGG D.;FIDA ROSE;KOWALSKI MARK M. |
分类号 |
A61K31/5377 |
主分类号 |
A61K31/5377 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|